Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GMDA | Gamida Cell Ltd. | Director | $375K | Jan 31, 2024 | ||
ALVR | Allovir, Inc. | Director | $55.5K | Jun 6, 2024 | ||
FDMT | 4D Molecular Therapeutics, Inc. | Director | May 21, 2024 | |||
CABA | Cabaletta Bio, Inc. | Director | Jun 3, 2024 | |||
TCRR | TCR2 THERAPEUTICS INC. | Director | Jun 1, 2023 | |||
URGN | UroGen Pharma Ltd. | Director | Jun 7, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|